US sharemarkets fell on Monday, dragged down by weakness in healthcare and biotechnology companies. There was also caution ahead of the earnings result from Apple and the Federal Reserve interest rate decision.
Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X
Recent Posts
- Nio Electric Sedan Takes Aim at Luxury RivalsDecember 23, 2024
- Navigating the Complex Landscape of Modern GovernmentDecember 23, 2024
- Navigating the Complex Landscape of Modern PoliticsDecember 23, 2024
- Unveiling the Secrets of Sustainable Living: Practical...December 23, 2024
- Unveiling the Power of Adaptive Learning: How Personalized...December 23, 2024
All Categories
- Battery Technology (2)
- Biotechnology (101)
- brekkie wrap (20)
- Broker News (2466)
- Commodities (1680)
- Hydrogen (6)
- Lithium (106)
- Potash (11)
- Rare Earths (6)
- Renewables (35)
- Company (6)
- Corporate Connect Research (24)
- Currencies (42)
- Cryptocurrencies (28)
- daily special (35)
- David Bassanese (90)
- Economics (3084)
- ESG (117)
- Etfs (500)
- EV Space (128)
- FinTech (26)
- Fixed Interest (231)
- FNN Content (6113)
- Franklin Templeton (1)
- fresh grind (10)
- fundie guide (21)
- Funds (1422)
- Gavin Wendt (141)
- Greg Tolpigin (75)
- hot stocks (25)
- Infrastructure (28)
- Interest Rates (386)
- investor blend (27)
- IPOs (20)
- James Dunn (185)
- Kris Walesby (67)
- LICs (162)
- Marc Sinatra (4)
- market mocha (19)
- Market Reports Text (283)
- Markets (14003)
- Media (71)
- Noosa Mining Conference (29)
- Podcasts (1)
- Politics (53)
- Product Profiles (23)
- Property (225)
- Reports (511)
- Retail (254)
- round table (8)
- Shane Oliver (260)
- Shares (18216)
- Stocks of the Hour (300)
- sip & learn (20)
- sip and learn (20)
- Sponsored Content (32)
- Strategy (204)
- Super (36)
- table for two (12)
- Technical Analysis (5)
- Technology (419)
- The Week that Was (112)
- Tim Boreham (85)
- Uncategorized (157)
- Video (4332)
- Webinars (195)
- Weekly Wrap (821)